Mattias Jangard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mattias Jangard has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Alma Andersson
Genentech Inc
2 shared publications - Camilla Engblom
Department of Cell and Molecular Biology, Karolinska Institutet, Solna, Sweden
2 shared publications - Christopher Andrew Tibbitt
Centre for Infectious Medicine, Department of Medicine Huddinge Karolinska Institutet and Karolinska University Hospital Stockholm Sweden
2 shared publications Efthymia Kokkinou
Department of Oncology Bloomberg Kimmel Institute of Cancer Immunotherapy Johns Hopkins University School of Medicine Baltimore Maryland USA
2 shared publicationsEmbla Steiner
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
2 shared publications- Jeff Mold
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (10)
PGE2 Enhances Human ILC3 Function but Constrains ILC2‐to‐ILC3 Plasticity
Type 2 innate lymphoid cells (ILC2) drive eosinophilic asthma, whereas ILC3 and plastic ILC2/3 states are implicated in neutrophilic and mixed granulocytic disease endotypes. While lipid mediators regulate ILC2 function and airway inflammation, their role in human ILC3 biology and ILC plasticity remains poorly defined. We investigated how eicosanoid biosynthesis and signalling regulate human ILC2 and ILC3 function across canonical and plastic states. Here, we identified distinct prostaglandin (PG) profiles across ILC subsets. Unlike ILC2, which produce and rely on PGD 2 , ILC3 produced PGE 2 , which stimulated their release of IL‐17F and IL‐22. ILC2‐to‐ILC3 plasticity induced a biosynthetic switch towards PGE 2 production that correlated with IL‐17A and IL‐17F expression. However, subset‐intrinsic prostaglandin responses were preserved: hybrid ILC2/3 phenotypes, unlike bona fide ILC3, remained susceptible to PGE 2 ‐mediated inhibition, indicating a key functional distinction between these populations.Collectively, our data identify PGE 2 as a central regulator of ILC3 function, paralleling the role of PGD 2 in ILC2. These findings position PGs as key orchestrators of ILC subset function and plasticity and provide mechanistic insights into the regulation of ILC3 and hybrid ILC2/3 phenotypes associated with neutrophilic and mixed granulocytic asthma.
- 8 October 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (10)
Open AccessPGE2 Enhances Human ILC3 Function but Constrains ILC2‐to‐ILC3 Plasticity
Type 2 innate lymphoid cells (ILC2) drive eosinophilic asthma, whereas ILC3 and plastic ILC2/3 states are implicated in neutrophilic and mixed granulocytic disease endotypes. While lipid mediators regulate ILC2 function and airway inflammation, their role in human ILC3 biology and ILC plasticity remains poorly defined. We investigated how eicosanoid biosynthesis and signalling regulate human ILC2 and ILC3 function across canonical and plastic states. Here, we identified distinct prostaglandin (PG) profiles across ILC subsets. Unlike ILC2, which produce and rely on PGD 2 , ILC3 produced PGE 2 , which stimulated their release of IL‐17F and IL‐22. ILC2‐to‐ILC3 plasticity induced a biosynthetic switch towards PGE 2 production that correlated with IL‐17A and IL‐17F expression. However, subset‐intrinsic prostaglandin responses were preserved: hybrid ILC2/3 phenotypes, unlike bona fide ILC3, remained susceptible to PGE 2 ‐mediated inhibition, indicating a key functional distinction between these populations.Collectively, our data identify PGE 2 as a central regulator of ILC3 function, paralleling the role of PGD 2 in ILC2. These findings position PGs as key orchestrators of ILC subset function and plasticity and provide mechanistic insights into the regulation of ILC3 and hybrid ILC2/3 phenotypes associated with neutrophilic and mixed granulocytic asthma.
- 10 October 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (11) , 1054-1063
Assessment of health-related quality of life and olfactory loss in relation to nasal polyp recurrence after endoscopic sinus surgery in patients with chronic rhinosinusitis: a real life-study
Chronic rhinosinusitis with nasal polyps (CRSwNP) impacts the health-related quality of life (HrQoL) and sense of smell. The association between recurrent NPs after surgery and patient-reported outcomes has not been extensively studied. To investigate whether patients with recurrent NPs can be distinguished from non-recurrent cases based on pre- and postsurgical evaluations of HrQoL, sense of smell, blood eosinophils and fractional exhaled nitric oxide (FeNO). Thirty-five patients with CRSwNP were recruited pre-surgery and followed up to 12 months post-surgery. HrQoL was assessed with RAND-36 and SNOT-22, olfactory dysfunction with smell test and self-reported. SNOT-22 scores improved 6 months post-surgery but deteriorated 12 months post-surgery with no significant difference related to recurrent NPs. Patients with recurrent NPs had lower smell test scores and more frequent self-reported anosmia or hyposmia as well as higher blood eosinophil counts at pre-surgery. FeNO did not change post-surgery and was not related to NP recurrence. A low smell test result before surgery may serve as an early indicator of recalcitrant NPs, whereas preoperative scores from HrQoL questionnaires may not be a good predictor. We confirm a significant role for blood eosinophils in refractory CRSwNP, while FeNO may not predict rapid NP recurrence.
- 10 October 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (11) , 1054-1063
Assessment of health-related quality of life and olfactory loss in relation to nasal polyp recurrence after endoscopic sinus surgery in patients with chronic rhinosinusitis: a real life-study
Chronic rhinosinusitis with nasal polyps (CRSwNP) impacts the health-related quality of life (HrQoL) and sense of smell. The association between recurrent NPs after surgery and patient-reported outcomes has not been extensively studied. To investigate whether patients with recurrent NPs can be distinguished from non-recurrent cases based on pre- and postsurgical evaluations of HrQoL, sense of smell, blood eosinophils and fractional exhaled nitric oxide (FeNO). Thirty-five patients with CRSwNP were recruited pre-surgery and followed up to 12 months post-surgery. HrQoL was assessed with RAND-36 and SNOT-22, olfactory dysfunction with smell test and self-reported. SNOT-22 scores improved 6 months post-surgery but deteriorated 12 months post-surgery with no significant difference related to recurrent NPs. Patients with recurrent NPs had lower smell test scores and more frequent self-reported anosmia or hyposmia as well as higher blood eosinophil counts at pre-surgery. FeNO did not change post-surgery and was not related to NP recurrence. A low smell test result before surgery may serve as an early indicator of recalcitrant NPs, whereas preoperative scores from HrQoL questionnaires may not be a good predictor. We confirm a significant role for blood eosinophils in refractory CRSwNP, while FeNO may not predict rapid NP recurrence.
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- Open Access
Spatial transcriptomics of T and B cell receptors uncovers lymphocyte clonal dynamics in human tissue
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed Spatial Transcriptomics of VDJ sequences (Spatial VDJ), which maps immunoglobulin and TR antigen receptors in human tissue sections. Spatial VDJ captures lymphocyte clones matching canonical T, B, and plasma cell distributions in tissues and amplifies clonal sequences confirmed by orthogonal methods. We confirm spatial congruency between paired receptor chains, develop a computational framework to predict receptor pairs, and link the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity, class switch recombination, and lineage trajectories within their spatial context. Taken together, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, which could have important therapeutic implications. One-Sentence Summary: Spatial transcriptomics-based technology co-captures T and B cell receptors within their anatomical niche in human tissue.
Open AccessSpatial transcriptomics of T and B cell receptors uncovers lymphocyte clonal dynamics in human tissue
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed Spatial Transcriptomics of VDJ sequences (Spatial VDJ), which maps immunoglobulin and TR antigen receptors in human tissue sections. Spatial VDJ captures lymphocyte clones matching canonical T, B, and plasma cell distributions in tissues and amplifies clonal sequences confirmed by orthogonal methods. We confirm spatial congruency between paired receptor chains, develop a computational framework to predict receptor pairs, and link the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity, class switch recombination, and lineage trajectories within their spatial context. Taken together, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, which could have important therapeutic implications. One-Sentence Summary: Spatial transcriptomics-based technology co-captures T and B cell receptors within their anatomical niche in human tissue.
- 15 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (70) , eabj8301
CD45RA + CD62L − ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs
Innate lymphoid cells (ILCs) are highly plastic and predominantly mucosal tissue-resident cells that contribute to both homeostasis and inflammation depending on the microenvironment. The discovery of naïve-like ILCs suggests an ILC differentiation process that is akin to naïve T cell differentiation. Delineating the mechanisms that underlie ILC differentiation in tissues is crucial for understanding ILC biology in health and disease. Here, we showed that tonsillar ILCs expressing CD45RA lacked proliferative activity, indicative of cellular quiescence. CD62L distinguished two subsets of CD45RA + ILCs. CD45RA + CD62L + ILCs (CD62L + ILCs) resembled circulating naïve ILCs because they lacked the transcriptional, metabolic, epigenetic, and cytokine production signatures of differentiated ILCs. CD45RA + CD62L − ILCs (CD62L − ILCs) were epigenetically similar to CD62L + ILCs but showed a transcriptional, metabolic, and cytokine production signature that was more akin to differentiated ILCs. CD62L + and CD62L − ILCs contained uni- and multipotent precursors of ILC1s/NK cells and ILC3s. Differentiation of CD62L + and CD62L − ILCs led to metabolic reprogramming including up-regulation of genes associated with glycolysis, which was needed for their effector functions after differentiation. CD62L − ILCs with preferential differentiation capacity toward IL-22–producing ILC3s accumulated in the inflamed mucosa of patients with inflammatory bowel disease. These data suggested distinct differentiation potential of CD62L + and CD62L − ILCs between tissue microenvironments and identified that manipulation of these cells is a possible approach to restore tissue-immune homeostasis.
- 15 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (70) , eabj8301
CD45RA + CD62L − ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs
Innate lymphoid cells (ILCs) are highly plastic and predominantly mucosal tissue-resident cells that contribute to both homeostasis and inflammation depending on the microenvironment. The discovery of naïve-like ILCs suggests an ILC differentiation process that is akin to naïve T cell differentiation. Delineating the mechanisms that underlie ILC differentiation in tissues is crucial for understanding ILC biology in health and disease. Here, we showed that tonsillar ILCs expressing CD45RA lacked proliferative activity, indicative of cellular quiescence. CD62L distinguished two subsets of CD45RA + ILCs. CD45RA + CD62L + ILCs (CD62L + ILCs) resembled circulating naïve ILCs because they lacked the transcriptional, metabolic, epigenetic, and cytokine production signatures of differentiated ILCs. CD45RA + CD62L − ILCs (CD62L − ILCs) were epigenetically similar to CD62L + ILCs but showed a transcriptional, metabolic, and cytokine production signature that was more akin to differentiated ILCs. CD62L + and CD62L − ILCs contained uni- and multipotent precursors of ILC1s/NK cells and ILC3s. Differentiation of CD62L + and CD62L − ILCs led to metabolic reprogramming including up-regulation of genes associated with glycolysis, which was needed for their effector functions after differentiation. CD62L − ILCs with preferential differentiation capacity toward IL-22–producing ILC3s accumulated in the inflamed mucosa of patients with inflammatory bowel disease. These data suggested distinct differentiation potential of CD62L + and CD62L − ILCs between tissue microenvironments and identified that manipulation of these cells is a possible approach to restore tissue-immune homeostasis.